One-step fabrication of inorganic/organic hybrid microspheres with tunable surface texture for controlled drug release application

Journal of Materials Science: Materials in Medicine

Volumn 27, Issue 1, 2016, Pages 1-8

  Dong, Hua ^a   Tang, Guannan ^a   Ma, Ting ^a,b   Cao, Xiaodong ^a,b  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^b NATIONAL ENGINEERING RESEARCH CENTER FOR TISSUE RESTORATION AND RECONSTRUCTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DROPS; EFFICIENCY; ENCAPSULATION; MICROSPHERES;

CONTROLLED DRUG RELEASE; DROPLET SURFACES; DROPLET-BASED MICROFLUIDICS; DRUG ENCAPSULATION EFFICIENCY; DRUG-RELEASE RATE; HYBRID MICROSPHERES; INORGANIC/ORGANIC HYBRID; TITANIUM TETRAISOPROPOXIDE;

DRUG PRODUCTS;

ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT; DRUG CARRIER; INORGANIC HYBRID MICROSPHERE; MICROSPHERE; ORGANIC HYBRID MICROSPHERE; POLYGLACTIN; TANSHINONE IIA; TITANIUM; UNCLASSIFIED DRUG; DRUG; INORGANIC COMPOUND; ORGANIC COMPOUND;

ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED DRUG RELEASE; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG MONITORING; DRUG RELEASE; ENCAPSULATION; HYDROLYSIS; HYDROPHILICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MALIGNANT NEOPLASTIC DISEASE; MICROTECHNOLOGY; PARTICLE SIZE; PHASE TRANSITION; PRIORITY JOURNAL; SALVIA MILTIORRHIZA; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TITANIUM TETRAISOPROPOXIDE; CHEMISTRY;

HYDROLYSIS; INORGANIC CHEMICALS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; ORGANIC CHEMICALS; PHARMACEUTICAL PREPARATIONS; SURFACE PROPERTIES;

EID: 84948157772     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-015-5624-y     Document Type: Article

References (28)

1. Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm. 2004;282:1–18.
2. Tran VT, Benoit JP, Venier-Julienne MC. Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy? Int J Pharm. 2011;407:1–11.
3. Tan ML, Choong PFM, Dass CR. Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides. 2010;31:184–93.
4. Andrianov AK, Payne LG. Polymeric carriers for oral uptake of microparticulates. Adv Drug Deliv Rev. 1998;34:155–70.
5. Musyanovych A, Landfester K. Polymer micro- and nanocapsules as biological carriers with multifunctional properties. Macromol Biosci. 2014;14:458–77.
6. Oliveira MB, Mano JF. Polymer-based microparticles in tissue engineering and regenerative medicine. Biotechnol Prog. 2011;27:897–912.
7. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives. J Control Release. 2008;125:193–209.
8. Parent M, Nouvel C, Koerber M, Sapin A, Maincent P, Boudier A. PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release. J Control Release. 2013;172:292–304.
9. Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm. 2008;364:298–327.
10. Jiang WL, Gupta RK, Deshpande MC, Schwendeman SP. Biodegradable poly(lactic-co- glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev. 2005;57:391–410.
11. Ungaro F, Angelo I, Miro A, La Rotonda MI, Quaglia F. Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises. J Pharm Pharmacol. 2012;64:1217–35.
12. Natarajan JV, Nugraha C, Ng XW, Venkatraman S. Sustained-release from nanocarriers: a review. J Control Release. 2014;193:122–38.
13. Berkland C, Kipper MJ, Narasimhan B, Kim K, Pack DW. Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres. J Control Release. 2004;94:129–41.
14. Dunne M, Corrigan OI, Ramtoola Z. Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials. 2000;21:1659–68.
15. Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release. 2005;102:313–32.
16. Cho DD, Yoo HJ. Microfabrication methods for biodegradable polymeric carriers for drug delivery system applications: a review. J Microelectromech S. 2015;24:10–8.
17. Lee WL, Widjaja E, Loo SCJ. One-step fabrication of triple-layered polymeric microparticles with layer localization of drugs as a novel drug-delivery system. Small. 2010;6:1003–11.
18. Duncanson WJ, Lin T, Abate AR, Seiffert S, Shah RK, Weitz DA. Microfluidic synthesis of advanced microparticles for encapsulation and controlled release. Lab Chip. 2012;12:2135–45.
19. Xu Q, Hashimoto M, Dang TT, Hoare T, Kohane DS, Whitesides GM, Langer R, Anderson DG. Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery. Small. 2009;5:1575–81.
20. Garcia-Munoz RA, Morales V, Linares M, Gonzalez PE, Sanz R, Serrano DP. Influence of the structural and textural properties of ordered mesoporous materials and hierarchical zeolitic supports on the controlled release of methylprednisolone hemisuccinate. J Mater Chem B. 2014;45:7996–8004.
21. Tang GN, Li WX, Cao XD, Dong H. In situ microfluidic fabrication of multi-shape inorganic/organic hybrid particles with controllable surface texture and porous internal structure. RSC Adv. 2015;5:12872–8.
22. Li WX, Dong H, Tang GN, Ma T, Cao XD. Controllable microfluidic fabrication of Janus and microcapsule particles for drug delivery applications. RSC Adv. 2015;5:23181–8.
23. Abbaspourrad A, Carroll NJ, Kim SH, Weitz DA. Adv Mater. 2013;25:3215–21.
24. Dubinsky S, Zhang H, Nie ZH, Gourevich I, Voicu D, Deetz M, Kumacheva E. Macromolecules. 2008;41:3555–61.
25. 2 nanocomposites as a “smart” pH-responsive drug delivery system. Int J Nanomed. 2012;7:235–42.
26. Lee J, Snyder JK. Ultrasound-promoted diels-alder reactions: syntheses of tanshinone IIA, nortanshinone, and (f)-tanshindiol B. J Am Chem Soc. 1989;111:1522–4.
27. Takahashi K, Ouyang X, Komatsu K, Nakamura N, Hattori M, Baba A, Azuma J. Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cells. Biochem Pharmacol. 2002;64:745–50.
28. Sokolsky-Papkov M, Agashi K, Olaye A, Shakesheff K, Domb AJ. Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev. 2007;59:187–206.